一个重链性粉样性肠病的案例:诊断挑战和临床影响
Francisco Laranjeira1, Bernardo Neves1, Paulo Bernardo2
1Department of Internal Medicine, Hospital da Luz, Lisbon, Portugal.
European journal of case reports in internal medicine
|March 8, 2024
概括
免疫球蛋白重链氨基粉症 (AH氨基粉症) 是一种罕见的疾病,具有诊断挑战. 质谱法有助于识别粉样蛋白类型,这对于治疗这种罕见疾病至关重要.
科学领域:
- 内分泌学 在内分泌学.
- 病理学 病理学 病理学
- 免疫学 免疫学 免疫学
背景情况:
- 免疫球蛋白重链氨基粉症 (AH氨基粉症) 是一种罕见的免疫球蛋白衍生的氨基粉症亚型.
- 有限的文献存在于诊断和管理AH Amyloidosis.
- 粉样性肠是这种疾病的一个非常罕见的表现.
研究的目的:
- 描述一种罕见的AH氨基粉症病例,表现为氨基.
- 突出质谱在粉样蛋白识别中的作用.
- 讨论这种罕见实体对诊断和管理的影响.
主要方法:
- 一个患有粉样质的患者的病例报告.
- 使用质谱测量用于粉样蛋白类型.
- 审查了关于AH氨基粉症的现有文献.
主要成果:
- 通过质谱学成功识别了粉样蛋白类型.
- 这个案例说明了AH氨基粉症的诊断复杂性.
- 观察表明临床表现,预后和诊断的潜在差异.
结论:
- 甲状腺 Amyloidosis 和 Amyloid 非常罕见,诊断和管理指南有限.
- 这一案例强调了与AH氨基粉症相关的诊断挑战.
- 质谱测量对于准确的粉样蛋白识别至关重要.
相关概念视频
Myasthenia Gravis: Diagnostic Tests
831
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
831
Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K
Myasthenia Gravis: Overview and Treatment
1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K


